195 related articles for article (PubMed ID: 23996103)
1. Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis.
Soydinc S; Turkbeyler IH; Pehlivan Y; Soylu G; Goktepe MF; Bilici M; Zengin O; Kisacik B; Onat AM
Inflammation; 2014 Feb; 37(1):100-6. PubMed ID: 23996103
[TBL] [Abstract][Full Text] [Related]
2. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
[TBL] [Abstract][Full Text] [Related]
3. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
4. Can mean platelet volume and red blood cell distribution width show disease activity in rheumatoid arthritis?
Tecer D; Sezgin M; Kanık A; İncel NA; Çimen ÖB; Biçer A; Şahin G
Biomark Med; 2016 Sep; 10(9):967-74. PubMed ID: 27564580
[TBL] [Abstract][Full Text] [Related]
5. Altered mean platelet volume in patients with polymyositis and its association with disease severity.
Peng YF; Huang YX; Wei YS
Braz J Med Biol Res; 2016; 49(6):e5168. PubMed ID: 27191605
[TBL] [Abstract][Full Text] [Related]
6. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of data from a prospective cohort study.
Kim A; Kim Y; Kim GT; Ahn E; So MW; Sohn DH; Lee SG
Rheumatol Int; 2020 Jul; 40(7):1071-1079. PubMed ID: 32424613
[TBL] [Abstract][Full Text] [Related]
7. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
[TBL] [Abstract][Full Text] [Related]
8. Mean platelet volume as an indicator of disease activity in juvenile SLE.
Yavuz S; Ece A
Clin Rheumatol; 2014 May; 33(5):637-41. PubMed ID: 24567240
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study.
Ntelis K; Gkizas V; Filippopoulou A; Davlouros P; Alexopoulos D; Andonopoulos AP; Daoussis D
BMC Musculoskelet Disord; 2016 May; 17():213. PubMed ID: 27188755
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients.
Romaniello A; Rubattu S; Gigante A; Simonelli F; Grimaldi MC; D'Angelo A; Alunni D; Sada L; Gasperini ML; Marchitti S; Volpe M; Rosato E
J Cardiovasc Med (Hagerstown); 2019 Nov; 20(11):771-779. PubMed ID: 31397686
[TBL] [Abstract][Full Text] [Related]
11. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
[TBL] [Abstract][Full Text] [Related]
13. Mean platelet volume (MPV): new diagnostic indices for co-morbidity of tuberculosis and diabetes mellitus.
Xu F; Qu S; Wang L; Qin Y
BMC Infect Dis; 2021 May; 21(1):461. PubMed ID: 34016046
[TBL] [Abstract][Full Text] [Related]
14. Serum defensin levels in patients with systemic sclerosis.
Gedik TE; Kucuk H; Goker B; Haznedaroglu S; Pasaoglu H; Varan O; Ozturk MA; Pasaoglu OT; Tufan A
Adv Rheumatol; 2020 Dec; 60(1):54. PubMed ID: 33353556
[TBL] [Abstract][Full Text] [Related]
15. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis.
Safak S; Uslu AU; Serdal K; Turker T; Soner S; Lutfi A
Afr Health Sci; 2014 Dec; 14(4):919-24. PubMed ID: 25834502
[TBL] [Abstract][Full Text] [Related]
16. Association between mean platelet volume and severity of rheumatoid arthritis.
Moghimi J; Ghahremanfard F; Salari M; Ghorbani R
Pan Afr Med J; 2017; 27():276. PubMed ID: 29187945
[TBL] [Abstract][Full Text] [Related]
17. Overlooked hematological markers of disease activity in rheumatoid arthritis.
Tekeoğlu İ; Gürol G; Harman H; Karakeçe E; Çiftçi İH
Int J Rheum Dis; 2016 Nov; 19(11):1078-1082. PubMed ID: 26620362
[TBL] [Abstract][Full Text] [Related]
18. Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.
Massabki PS; Silva NP; Lourenço DM; Andrade LE
J Rheumatol; 2003 Dec; 30(12):2606-12. PubMed ID: 14719201
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease.
Malerba M; Olivini A; Radaeli A; Ricciardolo FL; Clini E
Curr Med Res Opin; 2016 May; 32(5):885-91. PubMed ID: 26824631
[TBL] [Abstract][Full Text] [Related]
20. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
